NCT07867964

Brief Summary

While early onset schizophrenia spectrum disorders are among the most debilitating psychiatric illnesses, evidence-based treatment for this population is limited. This study evaluates the feasibility and acceptability of a parent peer co-led group intervention for caregivers of youth with Early Onset Schizophrenia Spectrum Disorder to support further refinement. Caregivers of youth with Early Onset Schizophrenia Spectrum Disorder will be invited to participate. Participants will be assigned to either the treatment group or the wait-list control group. Those in the treatment group will receive the group intervention immediately at study start and wait-list participants will be invited to participate following completion of the study. The group intervention consists of 10 group therapy intervention sessions covering psychosis psychoeducation (e.g. symptoms monitoring, stress \& stress management, family communication skills, and coping skills). Feasibility will be assessed through recruitment and retention, acceptability through the Client Satisfaction Questionnaire. Secondary aims include effectiveness using Goal Attainment Scaling (GAS), Perceived Stress Scale (PSS), and qualitative feedback from participants.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started May 2027

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 9, 2026

Completed
7 months until next milestone

Study Start

First participant enrolled

May 1, 2027

Expected
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

October 9, 2026

Status Verified

October 1, 2026

Enrollment Period

3 months

First QC Date

October 1, 2026

Last Update Submit

October 5, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Feasibility measured as attendance to the group sessions

    The average number of total group sessions attended

    Immediately following the last intervention session

  • Acceptability as measured on the Client Satisfaction Questionnaire-Participant Versions (CSQ)

    Client Satisfaction Questionnaire-Participant (CSQ) - used to assess acceptability of intervention, as defined by participant ratings on quality of service, fits of the intervention to meet need to support satisfaction, and overall satisfaction.

    Within two weeks following group intervention completion

Secondary Outcomes (2)

  • Effectiveness of the intervention as measured on progress on the Goal Attainment Scale (GAS)

    Within two weeks following group intervention completion

  • Social Validity

    Post-Intervention

Study Arms (2)

Treatment Group

EXPERIMENTAL

Participants in the Treatment Group will attend 10 group therapy sessions.

Behavioral: Group Therapy

Wait List Control Group

ACTIVE COMPARATOR

Participants in the wait-list control arm will serve as a comparison group for the duration of the primary intervention period. Upon completion of the primary study endpoints and post-tests, the wait-list control group will be offered the opportunity to receive the identical intervention.

Other: Treatment as Usual (TAU)

Interventions

Group TherapyBEHAVIORAL

The intervention consists of 10 sessions. Intervention sessions are held over a secure zoom platform, for 1-1.5 hrs, with up to 10 participants, once/week. The group will be facilitated by licensed psychologist. The group sessions will include, 1) Introductions, Goal Setting, Group Norms, Overview of Group, 2) Psychosis Psychoeducation, 3) Developmental Considerations, 4) Mental Health Systems \& Collaborating with Schools, 5) Role of Stress and Decreasing Stress in the Home, 6) Communication Skills, 7) Health Behaviors, 8) Coping Skills \& The Science of Psychosis, 9) Medications \& Prevention Planning, 10) Goal Setting \& Wrap-Up.

Treatment Group

Participants in the Waitlist group will receive treatment as usual (parent support and guidance from child's clinician, individual therapy for child, and psychopharmacological medication management for their child).

Wait List Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals who are 18 years old or older.
  • Individuals who are primary caregivers
  • Individuals are caregivers of a young person who meets criteria for EOSSD per clinician report.
  • Individuals who are fluent in English.

You may not qualify if:

  • Non-fluency in English.
  • Impaired decision making capacity per PI review.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Children's Hospital

Brookline, Massachusetts, 02445, United States

Location

Related Publications (14)

  • Lee JD, Terol AK, Yoon CD, Meadan H. Parent-to-parent support among parents of children with autism: A review of the literature. Autism. 2024 Feb;28(2):263-275. doi: 10.1177/13623613221146444. Epub 2023 Jan 1.

    PMID: 36588317BACKGROUND
  • Lammers EJ, Zickafoose JS, Peterson GG, Blue L, Stewart KA, Kranker K. Parent Partners: Evaluation of a Novel Peer-Support Intervention for the Caregivers of Children Hospitalized for Behavioral Health Conditions. Acad Pediatr. 2019 Nov-Dec;19(8):908-916. doi: 10.1016/j.acap.2019.06.001. Epub 2019 Jun 6.

    PMID: 31176786BACKGROUND
  • Day C, Michelson D, Thomson S, Penney C, Draper L. Evaluation of a peer led parenting intervention for disruptive behaviour problems in children: community based randomised controlled trial. BMJ. 2012 Mar 13;344:e1107. doi: 10.1136/bmj.e1107.

    PMID: 22416059BACKGROUND
  • Chien WT, Ho LK, Gray R, Bressington D. A randomized controlled trial of a peer-facilitated self-management program for people with recent-onset psychosis. Schizophr Res. 2022 Dec;250:22-30. doi: 10.1016/j.schres.2022.09.028. Epub 2022 Oct 13.

    PMID: 36242787BACKGROUND
  • Castelein S, Bruggeman R, van Busschbach JT, van der Gaag M, Stant AD, Knegtering H, Wiersma D. The effectiveness of peer support groups in psychosis: a randomized controlled trial. Acta Psychiatr Scand. 2008 Jul;118(1):64-72. doi: 10.1111/j.1600-0447.2008.01216.x.

    PMID: 18595176BACKGROUND
  • Rodolico A, Bighelli I, Avanzato C, Concerto C, Cutrufelli P, Mineo L, Schneider-Thoma J, Siafis S, Signorelli MS, Wu H, Wang D, Furukawa TA, Pitschel-Walz G, Aguglia E, Leucht S. Family interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis. Lancet Psychiatry. 2022 Mar;9(3):211-221. doi: 10.1016/S2215-0366(21)00437-5. Epub 2022 Jan 31.

    PMID: 35093198BACKGROUND
  • Camacho-Gomez M, Castellvi P. Effectiveness of Family Intervention for Preventing Relapse in First-Episode Psychosis Until 24 Months of Follow-up: A Systematic Review With Meta-analysis of Randomized Controlled Trials. Schizophr Bull. 2020 Jan 4;46(1):98-109. doi: 10.1093/schbul/sbz038.

    PMID: 31050757BACKGROUND
  • Calvo A, Moreno M, Ruiz-Sancho A, Rapado-Castro M, Moreno C, Sanchez-Gutierrez T, Arango C, Mayoral M. Psychoeducational Group Intervention for Adolescents With Psychosis and Their Families: A Two-Year Follow-Up. J Am Acad Child Adolesc Psychiatry. 2015 Dec;54(12):984-90. doi: 10.1016/j.jaac.2015.09.018. Epub 2015 Oct 13.

    PMID: 26598473BACKGROUND
  • Fusar-Poli P, McGorry PD, Kane JM. Improving outcomes of first-episode psychosis: an overview. World Psychiatry. 2017 Oct;16(3):251-265. doi: 10.1002/wps.20446.

    PMID: 28941089BACKGROUND
  • Morrison AP, Pyle M, Maughan D, Johns L, Freeman D, Broome MR, Husain N, Fowler D, Hudson J, MacLennan G, Norrie J, Shiers D, Hollis C, James A; MAPS group. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study. Lancet Psychiatry. 2020 Sep;7(9):788-800. doi: 10.1016/S2215-0366(20)30248-0. Epub 2020 Jul 7.

    PMID: 32649925BACKGROUND
  • Anagnostopoulou N, Kyriakopoulos M, Alba A. Psychological interventions in psychosis in children and adolescents: a systematic review. Eur Child Adolesc Psychiatry. 2019 Jun;28(6):735-746. doi: 10.1007/s00787-018-1159-3. Epub 2018 May 4.

    PMID: 29728871BACKGROUND
  • McDonagh MS, Dana T, Selph S, Devine EB, Cantor A, Bougatsos C, Blazina I, Grusing S, Fu R, Kopelovich SL, Monroe-DeVita M, Haupt DW. Treatments for Schizophrenia in Adults: A Systematic Review [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Oct. Report No.: 17(18)-EHC031-EF. Available from http://www.ncbi.nlm.nih.gov/books/NBK487628/

    PMID: 29537779BACKGROUND
  • Correll CU, Galling B, Pawar A, Krivko A, Bonetto C, Ruggeri M, Craig TJ, Nordentoft M, Srihari VH, Guloksuz S, Hui CLM, Chen EYH, Valencia M, Juarez F, Robinson DG, Schooler NR, Brunette MF, Mueser KT, Rosenheck RA, Marcy P, Addington J, Estroff SE, Robinson J, Penn D, Severe JB, Kane JM. Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression. JAMA Psychiatry. 2018 Jun 1;75(6):555-565. doi: 10.1001/jamapsychiatry.2018.0623.

    PMID: 29800949BACKGROUND
  • Kelleher I. Annual Research Review: Psychosis in children and adolescents: key updates from the past 2 decades on psychotic disorders, psychotic experiences, and psychosis risk. J Child Psychol Psychiatry. 2025 Apr;66(4):460-476. doi: 10.1111/jcpp.14088. Epub 2025 Jan 3.

    PMID: 39754377BACKGROUND

MeSH Terms

Conditions

SchizophreniaPsychotic Disorders

Interventions

Psychotherapy, GroupTherapeutics

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Socioenvironmental TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Bernalyn Ruiz-Yu, PhD

    Boston Children's Hospital, Harvard Medical School

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 1, 2026

First Posted

October 9, 2026

Study Start (Estimated)

May 1, 2027

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

October 9, 2026

Record last verified: 2026-10

Data Sharing

IPD Sharing
Will not share

Locations